Non-encapsulated Neisseria meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with the complement inhibitor pegcetacoplan

被引：0
|
作者：
Starck, Leo [1 ]
Nummi, Vuokko [2 ]
Poikonen, Eira [2 ]
Lehtinen, Anna [2 ]
Kivela, Pia [3 ]
Torvikoski, Jukka [4 ,5 ]
Friberg, Nathalie [4 ,5 ]
Toropainen, Maija [6 ]
Meri, Seppo [1 ]
机构：
[1] Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Helsinki, Finland
[2] Helsinki Univ Hosp, Comprehens Canc Ctr, Dept Hematol, Coagulat Disorders Unit, Helsinki, Finland
[3] Helsinki Univ Cent Hosp, Inflammat Ctr, Dept Infect Dis, Helsinki, Finland
[4] Univ Helsinki, HUS Diagnost Ctr, Dept Clin Microbiol, Helsinki, Finland
[5] Helsinki Univ Hosp, Helsinki, Finland
[6] Finnish Inst Hlth & Welf THL, Dept Hlth Secur, Helsinki, Finland
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 31
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [1] Non-capsulated Neisseria meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with ravulizumab: case report and review of the literature
    Galli, Nicole
    Pettine, Loredana
    Panigada, Mauro
    Daprai, Laura
    Suriano, Grazia
    Grancini, Anna
    Barcellini, Wilma
    Fattizzo, Bruno
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] Meningococcal Sepsis in Patient with Paroxysmal Nocturnal Hemoglobinuria during Pegcetacoplan Therapy
    Starck, Leo
    Nummi, Vuokko
    Poikonen, Eira
    Lehtinen, Anna-Elina
    Kivela, Pia
    Friberg, Nathalie
    Torvikoski, Jukka
    Toropainen, Maija
    Meri, Seppo
    EMERGING INFECTIOUS DISEASES, 2025, 31 (03) : 583 - 586
  • [3] Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria
    Wong, Raymond Siu Ming
    Navarro-Cabrera, Juan Ramon
    Comia, Narcisa Sonia
    Goh, Yeow Tee
    Idrobo, Henry
    Kongkabpan, Daolada
    Gomez-Almaguer, David
    Al-Adhami, Mohammed
    Ajayi, Temitayo
    Alvarenga, Paulo
    Savage, Jessica
    Deschatelets, Pascal
    Francois, Cedric
    Grossi, Federico
    Dumagay, Teresita
    BLOOD ADVANCES, 2023, 7 (11) : 2468 - 2478
  • [4] The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Young, Neal S.
    Schubert, Joerg
    Brodsky, Robert A.
    Socie, Gerard
    Muus, Petra
    Roeth, Alexander
    Szer, Jeffrey
    Elebute, Modupe O.
    Nakamura, Ryotaro
    Browne, Paul
    Risitano, Antonio M.
    Hill, Anita
    Schrezenmeier, Hubert
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw
    Rollins, Scott A.
    Mojcik, Christopher F.
    Rother, Russell P.
    Luzzatto, Lucio
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12): : 1233 - 1243
  • [5] Pegcetacoplan - a novel C3 inhibitor for paroxysmal nocturnal hemoglobinuria
    Rehan, Syeda Tayyaba
    Hashmi, Mahnoor Rehan
    Asghar, Muhammad Sohaib
    Tahir, Muhammad Junaid
    Yousaf, Zohaib
    HEALTH SCIENCE REPORTS, 2022, 5 (03)
  • [6] A Case Report of a Patient with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan Who Underwent Major Surgery
    Vara, Miriam
    Moreno, Maite
    Arzuaga, Javier
    Hormaza, Sara
    Garcia-Ruiz, Juan Carlos
    BLOOD, 2023, 142
  • [7] Monitoring of patients with paroxysmal nocturnal hemoglobinuria on a complement inhibitor
    Kulasekararaj, Austin G.
    Brodsky, Robert A.
    Hill, Anita
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : E232 - E235
  • [8] BUDGET IMPACT OF PEGCETACOPLAN, A COMPLEMENT C3 INHIBITOR, FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN US ADULTS
    Anderson, S.
    Talbird, S. E.
    Fishman, J.
    Mody-Patel, N.
    Sarda, S. P.
    VALUE IN HEALTH, 2022, 25 (01) : S89 - S89
  • [9] Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria
    Bo Xu
    Clinical and Experimental Medicine, 2023, 23 : 717 - 726
  • [10] Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria
    Xu, Bo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (03) : 717 - 726
12345